Valuation APTOCROM Inc.

Stocks

End-of-day quote Korea S.E. 11/09/2026			5-day change	1st Jan Change
1,902.00 ^KRW	+2.59%		+5.26%	-61.96%

03/09	Aprogen Medicines Inc. announced that it expects to receive KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc.	CI
13/08	APTOCROM Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	1,32,471	1,25,151	66,950	51,548	1,04,593	55,188
Change	-	-5.53%	-46.5%	-23.01%	102.9%	-47.23%
Enterprise Value (EV) ¹	1,01,306	69,004	-14,380	55,057	79,526	37,996
Change	-	-31.89%	-120.84%	482.87%	44.44%	-52.22%
P/E	12x	47.2x	-11.9x	24x	-2.12x	-9.5x
PBR	0.57x	0.56x	0.34x	0.31x	0.35x	0.18x
PEG	-	-0.6x	0x	-0x	0x	0.1x
Capitalization / Revenue	12.8x	14.9x	6.98x	3.22x	6.38x	5.63x
EV / Revenue	9.82x	8.2x	-1.5x	3.44x	4.85x	3.87x
EV / EBITDA	4,671x	-31.8x	1.22x	-2.69x	83.9x	-2.32x
EV / EBIT	-270x	-26.8x	1.19x	-2.62x	154x	-2.27x
EV / FCF	-1.98x	5.77x	-0.46x	13.1x	-32.9x	-1.9x
FCF Yield	-50.6%	17.3%	-216%	7.65%	-3.04%	-52.7%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	6,200	1,484	-3,140	648.5	-4,924	-526.5
Distribution rate	-	-	-	-	-	-
Net sales ¹	10,319	8,416	9,598	16,007	16,400	9,807
EBITDA ¹	21.69	-2,167	-11,810	-20,454	947.7	-16,372
EBIT ¹	-375.2	-2,579	-12,099	-21,004	517.3	-16,737
Net income ¹	11,084	2,650	-5,607	4,304	-28,094	-5,559
Net Debt ¹	-31,165	-56,147	-81,330	3,509	-25,067	-17,192
Reference price ²	74,200.00	70,100.00	37,500.00	15,580.00	10,420.00	5,000.00
Nbr of stocks (in thousands)	1,785	1,785	1,785	3,309	10,038	11,038
Announcement Date	15/03/21	14/03/22	17/03/23	13/03/24	14/03/25	20/03/26

¹KRW in Million²KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
APTOCROM INC.	-	-	-	-	2.08Cr
ELI LILLY AND COMPANY	31.96x	11.62x	23.56x	0.62%	1,00100Cr
JOHNSON & JOHNSON	29.63x	-	-	2.02%	64TCr
ABBVIE INC.	32.65x	7.56x	15.72x	2.69%	45TCr
ROCHE HOLDING AG	18.78x	4.58x	11.35x	2.9%	34TCr
NOVARTIS AG	19.52x	5.11x	12.66x	3.19%	26TCr
ASTRAZENECA PLC	20.44x	4.2x	12.01x	2.1%	25TCr
AMGEN INC.	24.19x	6.38x	11.35x	2.64%	21TCr
NOVO NORDISK A/S	12.74x	4.63x	9.67x	3.94%	20TCr
GILEAD SCIENCES, INC.	-43.8x	6.4x	24.98x	2.27%	18TCr
Average	16.23x	6.31x	15.16x	2.48%	35.26TCr
Weighted average by Cap.	23.23x	7.75x	17.18x	2.04%